Specialized pro-resolving lipid mediators (SPMs) and their potential
contribution to the resolution of inflammatory processes associated to
PCOS represents a chronic disease affecting between 8 -10 % of women
during their reproductive life. Concepts were developed that re-define
inflammation as being composed of the inflammatory response and active
resolution processes, which occur at the same time. Key players are the
specialized pro-resolving lipid mediators (SPMs).